High serum levels of uric acid are associated with an increased risk of developing gout, hypertension, cardiovascular disease and renal failure. Urate is produced as a result of purine degradation and as yet little is known about the pathway for urate efflux from cells. In the May Journal of Clinical Investigation Michael Lipkowitz and colleagues from the Mount Sinai School of Medicine, New York provide data on the human urate transporter galectin 9.Lipkowitz et al show that a recombinant protei
High serum levels of uric acid are associated with an increased risk of developing gout, hypertension, cardiovascular disease and renal failure. Urate is produced as a result of purine degradation and as yet little is known about the pathway for urate efflux from cells. In the May
Lipkowitz
...
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and spot the effects of excipients on protein stability.
Designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud
System strengthens Taiwan’s capabilities in protein drug discovery research
The Transferpette® pro expands the Transferpette® family, offering scientists even greater flexibility to match their pipetting preferences and workflow requirements.
